Patents (1436 Stem Cell Patents)

Class: Expansion (424)

Order by:
<< | < | 10 11 12 13 14 15 16 17 18 | > | >>


Loop peptide and TGF.alpha. for stimulating stem cell proliferation and migration

Patent Number: 7,365,172

Stem cells need to be maintained in a quiescent state when they are not needed to make new cells.  This is because if stem cells were consistently proliferating then there would be a high propability of mutations, thus leading to cancer.  One of the methods that stem cells maintain themselves in a non-proliferating state is through autocrine secretion of inhibitory factors. ...

Inventors: Twardzik; Daniel R (Bainbridge Island, WA), Paskell; Stefan (Bainbridge Island, WA), Felker; Thomas S (Vashon, WA)
Assignee: Applied Protein Sciences LLC (Mountain View, CA)
Date of First Priority Issue: Monday April 26th, 1999

Loop peptide and TGF.alpha. for stimulating stem cell proliferation and migration

Patent Number: 6764683

Mucositis is a big problem in cancer patients taking chemotherapy and radiation therapy, in part due to the effect of these therapies on the epithelial stem cell pool. This patent teaches the usefulness of transforming growth factor alpha on preventing this condition by its ability to protect the stem cell compartment and to enhance their expansion.

Inventors: Twardzik, Daniel R. (Bainbridge Island, WA); Paskell, Stefan (Bainbridge Island, WA); Felker, Thomas S. (Vashon, WA)
Assignee: Kaleidos Pharma, Inc. (Seattle, WA)
Date of First Priority Issue: Monday April 26th, 1999

Method for ex-vivo expansion of hematopoietic cells

Patent Number: 6251383

This patent covers the use of an extract of the plant called Tinospora cordifolia for stimulation of hematopoietic stem cells.

Inventors: Upadhyay, Shakti N. (New Delhi, IN); Madan, Vikas (New Delhi, IN)
Assignee: National Institute of Immunology (New Delhi, IN)
Date of First Priority Issue: Tuesday April 20th, 1999

G-CSF mimetics

Patent Number: 6346531

This patent provides compositions of matter that are useful for stimulating the receptor for granulocyte colony stimulating factor. The fact that G-CSF was the first drug introduced that acted on the level of stem cells suggests that this is an important area for drug development. This patent may be useful not only for stimulation of neutrophil function, but also for increasing stem...

Inventors: Luengo, Juan I (Audubon, PA); Duffy, Kevin J (Norristown, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Date of First Priority Issue: Saturday March 20th, 1999

Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction

Patent Number: 6790838

This patent teaches ways of improving the transfection of liver cells with genes in vivo. Transfection of liver cells is performed through the administration of the thyroid hormone T3, as well as keratinocyte growth factor. The transfection of liver cells may be performed not only for treatment of genetic disorders, but also for induction of islet...

Inventors: Alison, Malcolm R. (London, GB); Coutelle, Charles (London, GB); Forbes, Stuart J. (London, GB); Hodgson, Humphrey J. F. (London, GB); Sarosi, Ildiko (Newbury Park, CA); Themis, Michael (Oxfordshire, GB)
Assignee: Amgen, Inc. (Thousand Oaks, CA); Imperial College Innovations LTD (London, GB)
Date of First Priority Issue: Tuesday February 23rd, 1999

Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction

Patent Number: 6248725

This is an interesting patent that teaches the concurrent administration of the thyroid hormone T3, together with keratinocyte growth factor (KGF) can stimulate proliferation of endogenous hepatic stem cells.

Inventors: Alison, Malcom R. (London, GB); Coutelle, Charles (London, GB); Forbes, Stuart J. (Middlesex, GB); Hodgson, Humphrey J. F. (London, GB); Sarosi, Ildiko (Thousand Oaks, CA); Themis, Michael (Buckinghamshire, GB)
Assignee: Amgen, Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Tuesday February 23rd, 1999

Proteins related to neuronal regeneration and uses thereof

Patent Number: 6783982

This patent teaches that neural stem cells can be expanded through the use of a novel protein called Neural Plakophilin Related Armadillo Protein (hNPRAP). Additionally the patent claims the induction of cellular extensions ushing hNPRAP.

Inventors: St. George-Hyslop, Peter H. (Toronto, CA); Fraser, Paul E. (Toronto, CA)
Assignee: The Governing Council of The University of Toronto (Toronto, CA)
Date of First Priority Issue: Friday February 12th, 1999

Propagation of human hepatocytes in non-human animals

Patent Number: 6995299

This patent teaches ways of growing human hepatocytes in xenogenic hosts. This patent would be useful for using animals as "bioincubators" in order to grow organs or cells for human use. Specifically the patent has two independent claims. The first covers a model of hepatitis C in which a mammal is injected with human hepatocytes when it is in the fetal stage, thus becoming...

Inventors: Wu, George Y. (Avon, CT); Wu, Catherine H. (Avon, CT)
Assignee: University of Connecticut (Farmington, CT)
Date of First Priority Issue: Thursday February 11th, 1999

Use of vascular endothelial growth factor to treat photoreceptor cells

Patent Number: 7,223,724

Macular degeneration and various other types of ocular pathology are usually associated with uncontrolled proliferation of blood vessels near the retina. The covering of nerves by new blood vessels usually causes dysfunction of the nerves and in some cases blindness. It is known that the compound VEGF is associated with pathological angiogenesis, and accordingly, the...

Inventors: Alderson; Ralph (Gaithersburg, MD), Melder; Robert (Boyds, MD), Roschke; Viktor (Rockville, MD), Ruben; Steven M. (Olney, MD), Rosen; Craig A. (Laytonsville, MD)
Assignee: Human Genome Sciences, Inc. (Rockville, MD)
Date of First Priority Issue: Monday February 8th, 1999

Method of expanding undifferentiated hemopoietic stem cells

Patent Number: 7,534,609

Expansion of hematopoietic stem cells would, at face value, allow the possibility of curing many hematological diseases by the process of selecting non-leukemic stem cells, ex vivo expanding them, and providing them back to the patient after myeloablation has destroyed the resident malignant cells.

Pluristem (Nasdaq:PSTI) is...

Inventors: Merchav; Shoshana (Haifa, IL), Meretski; Shai (Haifa, IL)
Assignee: Pluristem Life Systems Inc. (Haifa, IL)
Date of First Priority Issue: Thursday February 4th, 1999

Order by:
<< | < | 10 11 12 13 14 15 16 17 18 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent